Otsuka (OTCMKTS:OTSKY) Shares Gap Up – What’s Next?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s share price gapped up before the market opened on Monday . The stock had previously closed at $31.36, but opened at $32.70. Otsuka shares last traded at $31.15, with a volume of 6,167 shares changing hands.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on OTSKY shares. Morgan Stanley upgraded shares of Otsuka to an “overweight” rating in a research report on Friday, January 23rd. UBS Group upgraded Otsuka to a “hold” rating in a research report on Tuesday, January 27th. Zacks Research lowered Otsuka from a “hold” rating to a “strong sell” rating in a research note on Monday, March 2nd. Finally, The Goldman Sachs Group cut Otsuka from a “strong-buy” rating to a “strong sell” rating in a report on Friday, February 27th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce”.

Otsuka Stock Up 1.9%

The stock’s fifty day moving average price is $30.86 and its two-hundred day moving average price is $28.88.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.